Products
-
Pharma Asset Strategy I
CourseThis 10-module course will introduce you to the various concepts, terms, fields and research tools to perform indication analysis in drug development. Assessing the potential of a drug is at the core of pharma/biotech.
$600
-
Pharma Asset Strategy II
CourseComing Soon: This module introduces you to segmenting disease epidemiology, analyzing eligible populations, incorporating annual cost of therapies, all to build a revenue model and an asset valuation model. We start from scratch (blank sheet)!
$800
-
Strategy Development
CourseUpcoming: This course gives the basics and the process for strategy development. Using a pharma case study, we learn how to develop strategies using various frameworks, and how to present to an audience
$800
-
Pharma Asset Strategy I - Epi and Disease Burden
CourseThis chapter concentrates on key metrics in evaluating disease epidemiology, with absolute vs relative risk, as well as discusses disease burden involved in indication analyses.
$99
-
Pharma Asset Strategy I - Pharmacology, Treatment Flows and TPP
CourseThis chapter focuses on the basics of drug pharmacology, how to look at patient treatment flows and generating a Target Product Profile (TPP).
$99
-
Pharma Asset Strategy I - Clinical Development
CourseThis chapter introduces you to the full lifecycle of clinical development, with focus on clinical trial types, trial endpoints, trial success rates and trial costs.
$99